Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell wall and cytoplasmic membrane anionic components, such as phosphatidylglycerol (PG), cardiolipin, and teichoic acids, are essential for maintaining the structural integrity and electrochemical gradient of bacterial cells (Epand et al., 2016, Biochimica et Biophysica Acta). These negatively charged molecules serve as the primary docking sites for several classes of antibiotics, including lipopeptides and polymyxins (Heidary et al., 2022, Frontiers in Microbiology). For instance, daptomycin requires calcium ions to form complexes that specifically target PG in Gram-positive membranes, leading to rapid depolarization and potassium efflux (Taylor & Palmer, 2016, Antibiotics). In Gram-negative bacteria, the anionic lipid A component of lipopolysaccharide (LPS) is the target for polymyxins, which disrupt the outer membrane through a displacement of divalent cations (Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine). These interactions are crucial for the bactericidal activity of these drugs against multi-drug resistant pathogens like MRSA and carbapenem-resistant Enterobacteriaceae. Resistance often arises through the modification of these anionic components, such as the addition of L-lysine to PG by the MprF enzyme, which reduces the net negative charge and repels cationic drugs (Ernst & Peschel, 2011, Nature Reviews Microbiology).
Binding to anionic components via electrostatic interactions, often calcium-dependent, leading to membrane depolarization, pore formation, and cell death (Heidary et al., 2022, Frontiers in Microbiology; Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall and cytoplasmic membrane anionic components.